1. Contractors
  2. The Emmes Company, LLC

The Emmes Company, LLC

Federal contractor · Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

The Emmes Company has 92 federal contracts of $100,000 or more active since October 2023, with $742M obligated, from 2 agencies. 28 are still running, 25 ending within 18 months.

Contracts
92 since FY2024$742,115,551 obligated, contracts of $100,000 or more
Running now
28 contracts15 ended in the last 12 months
Biggest customer
National Institutes of Health$742M on 91 contracts
UEI
NBQCBJ6FXBU4Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2020$27,094,779
FY2021$240,631,256
FY2022$52,995,354
FY2023$26,794,665
FY2024$55,294,105
FY2025$13,374,330
FY2026$4,206,522

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Vrc 316/317/320/603 Clinical Monitoring: Pop: 5/1/19 - 3/28/21National Institutes of Health · 75N93019F00132$174,116Dec 31, 2026in 1 monthMD
Office-Based Methadone Vs Buprenorphine to Address Retention in Medication for Opioid Use Disorder (Moud)-a Pragmatic Hybrid Effectiveness/Implementation Trial (Ctn-013). 09/28/2022 - 08/04/2025…National Institutes of Health · 75N95022F00003$1,861,518Jan 31, 2027in 2 monthsMD
Standard and High Dose Ed Buprenorphine Induction. 09/15/2023 - 05/31/2026. N01DA-22-2253. Task Order 75N95023F00005 (TO9).National Institutes of Health · 75N95023F00005$1,249,376Jan 31, 2027in 2 monthsMD
Better Together: Integrating Moud in African American Community Settings. September 15, 2023 to January 31, 2026. N01DA-22-2253. Task Order 75N95023F00004 (TO8).National Institutes of Health · 75N95023F00004$999,995Jan 31, 2027in 2 monthsMD
Statistical and Data Coordinating Center for Clinical Research in Infectious Diseases (Sdcc)National Institutes of Health · 75N93021C00012$176,560,287Feb 28, 2027in 3 monthsMD
Dsc Management and Support. April 29, 2026 Through February 28, 2027. N01DA-22-2253. Task Order No. 75N98026F00002 (to 28)National Institutes of Health · 75N98026F00002$2,359,700Feb 28, 2027in 3 monthsMD
Clinical Research Support and Collaboration for Nhgri ProtocolsNational Institutes of Health · 75N92026F00002$190,729Feb 28, 2027in 3 monthsMD
Ketamine for Methamphetamine Use Disorder Study (Ctn-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).National Institutes of Health · 75N95022F00004$2,075,621Mar 31, 2027in 4 monthsMD
EO14042 Development, Statistical Design, Monitoring and Coordination of Vision Clinical Trials and Epidemiology ResearchNational Institutes of Health · 75N98022C00001$32,539,945Apr 30, 2027in 5 monthsMD
Clinical Research Support and Collaboration for Nhgri ProtocolsNational Institutes of Health · 75N98026F00001$401,624Apr 30, 2027in 5 monthsMD
Data Coordinating Center for the Best Pharmaceuticals for Children ActNational Institutes of Health · HHSN275201700002C$66,032,644May 28, 2027in 6 monthsMD
Clinical Trials and Information Management SupportNational Institutes of Health · 75N91021C00009$51,133,673May 31, 2027in 6 monthsMD
Task Area 4: Statistical Expertise for SbrbNational Institutes of Health · 75N98026F00005$115,000Jun 30, 2027in 7 monthsMD
Data Coordinating Center to Provide Services to Work Collaboratively With the National Neurohiv Tissue Consortium Clinical Sites to Provide Management and Database Capabilities, Scientific…National Institutes of Health · 75N95023C00013$13,535,405Aug 6, 2027in 8 monthsMD
FY23. to 11 - Ctn-0145: Standard Versus High Dose Ed-Initiated Buprenorphine Induction. Pop: 8/28/23 - 8/27/24.National Institutes of Health · 75N95023F00004$1,036,687Aug 27, 2027in 9 monthsMD
Logistical and IT Support for the Nci Central Individual Review Board (Cirb)National Institutes of Health · 75N91024C00024$27,417,478Aug 31, 2027in 9 monthsMD
Management of Unhealthy Opioid and Polysubstance Use Among Patients in Primary Care Settings. FY22. Pop 9/15/22 - 9/14/27.National Institutes of Health · 75N95022F00003$1,299,926Sep 14, 2027in 9 monthsMD
The Government Requires Contractor Support to Provide Continued Read-Only Access, Maintenance, Security Compliance, and Subsequent Decommissioning of the Vaccine Research Center (Vrc) Websites and…Office of the Assistant Secretary for Financial Resources · 7571TE26P00111$124,613Sep 14, 2027in 9 monthsMD
Ninds Center for Clinical Trial ResourcesNational Institutes of Health · 75N95022C00041$9,122,780Sep 29, 2027in 10 monthsMD
Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders (Sud) Among Hospitalized Patients (Ctn-0121). 09/28/2022 - 02/07/2026. DSC6. 75N95022F00002 (TO2).National Institutes of Health · 75N95022F00002$2,067,729Sep 30, 2027in 10 monthsMD
Dsc Management and Support. April 15, 2026 Through November 30, 2027 N01DA-22-2253, Task Order No. 75N98026F00001 (to 29) "collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)"National Institutes of Health · 75N98026F00001$669,860Nov 30, 2027in 12 monthsMD
Data and Statistical Analysis for Glp-1 As an Adjunct to Buprenorphine. May 21, 2025 - February 29, 2028. N01DA-22-2253. Task Order No. 75N95025F00002 (TO26).National Institutes of Health · 75N95025F00002$1,747,575Feb 29, 2028in 15 monthsMD
TO5. Clinical Coordinating Center for Nida's Clinical Trials Network. Contract Type: Idiq Task Order. Pop: 8/15/24 - 8/14/29National Institutes of Health · 75N95025F00002$2,501,452Mar 31, 2028in 16 monthsMD
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (Ctn-0100). August 15, 2024 to March 31, 2028. N01DA-22-2253. Task Order No. 75N95024F00007…National Institutes of Health · 75N95024F00007$1,860,579Mar 31, 2028in 16 monthsMD
Ctn's Clinical Coordinating Center Contract. Ctn Study, Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (Ctn-0100). Pop: 8/15/24 - 4/2/28National Institutes of Health · 75N95024F00003$3,944,274Apr 2, 2028in 16 monthsMD
Niaid Carrrp A2024-1 - Vrc 617National Institutes of Health · 75N93024F00001$223,398Jun 20, 2028in 19 monthsMD
Nichd:R&D:Data Coordinating Center for the Follow-Up of the Second Phase (Cohort 2) of the Prenatal and Childhood Mechanisms of Health Disparities Observational Study:Non-SeverableNational Institutes of Health · 75N94025F00001$1,387,469Oct 31, 2028in 23 monthsMD
Task Order 6 for the Ctn Clinical Research Coordinating Center (Ccc) ContractNational Institutes of Health · 75N98026F00001$4,960,819Aug 14, 2029in 32 monthsMD

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount, $M
National Institutes of Health91 contracts742.0
Office of the Assistant Secretary for Financial Resources1 contract0.1

Where the work is

Place of workAmount, $M
Maryland92 contracts742.1

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.

Get new notices like The Emmes Company's work

New contract opportunities under NAICS 541712, research and development in the physical, engineering, and life sciences (except biotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy